| Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies A Gatt, F Bonello, R Buttigieg, S Debono, P Brincat, C Grima, P Gatt, ... Blood Transfusion 12 (4), 479, 2014 | 15 | 2014 |
| Copper levels in patients with unexplained dysplastic cytopenia D Butcher, S Deplano, T Lofaro Biological Trace Element Research 199 (3), 825-828, 2021 | 3 | 2021 |
| The use of ultrasound in the diagnosis of Tenchkoff catheter tunnel infection R Debono, K Cortis, T Lofaro, L Buhagiar Malta Medical Journal, 2012 | 3 | 2012 |
| The Haemato‐Oncology Frailty (HOF) score to assess frailty in lymphoma H Ramdany, T Lofaro, S Deplano European Journal of Haematology 112 (4), 611-620, 2024 | 2 | 2024 |
| Non-malignant CSF lymphocytosis in a patient with acute lymphoblastic leukemia T Lofaro, A Saha, K Raj, R Dillon IDCases 14, e00447, 2018 | 1 | 2018 |
| Simple measures can improve care in our hospitals: an audit of venous thromboembolism practice T Lofaro, S Azzopardi, S Busuttil, J Cordina Malta Medical Journal, 2013 | 1 | 2013 |
| Utility of teg and flowcytometry to guide platelet transfusion requirement in patients with haematological malignancies S Debono, F Bonello, R Buttigieg, P Brincat, C Grima, T Lofaro, S Laspina, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11, 74-74, 2013 | | 2013 |
| Outcome of critically ill patients with haematological malignancy admitted to the ICU as an emergency T Lofaro, S Easdale, S Rowe, M Ostermann, R Carr Critical Care 17 (Suppl 2), P516, 2013 | | 2013 |
| A case of primary cardiac lymphoma with systemic involvement T Lofaro, A Betts, A Gatt CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 82, S26-S26, 2012 | | 2012 |
| An audit on venous thromboembolism prophylaxis in a geriatric facility S Busuttil, S Azzopardi, T Lofaro, J Cordina European Geriatric Medicine, S132, 2012 | | 2012 |
| A case of neuroleptic malignant syndrome on withdrawal of benzhexol T Lofaro, S Falzon, P Ferry Malta Medical Journal, 2010 | | 2010 |
| 8 year review of ICU and 6-month outcome of patients with haematological malignancy S Easdale, T Lofaro, V Stables, R Carr, M Ostermann Age (years) 51, 57.9, 0 | | |
